Cervical cancer Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.

Slides:



Advertisements
Similar presentations
Cervical Cancer.
Advertisements

In the name of God Isfahan medical school Shahnaz Aram MD.
MANAGEMENT OF THE ABNORMAL PAP SMEAR
Cervical Cancer. Dr. Swapna Chaudhary M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Cervical Cancer DR KHALID H. WALI SAIT (FRCSC) ASSOCIATE PROFESSOR OF GYNECOLOGICAL ONCOLOGY King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Cervical Cancer American Cancer Society Georgia Department of Human Resources The University of Georgia Cooperative Extension Service.
The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university The Dept. OB/GY of the first hospital of Xi’an Jiao Tong university Cervical carcinoma.
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Malignant disease of the cervix
Updates on Pap Smear Guidelines 2014
Speaker: Decca Mohammed, MD.  Statistics for cervical cancer and HPV  Association of HPV to cervical cancer, and other cancers  Prevention  Screening.
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
Carcinoma of the Vulva.
Cervical Cancer Keith Unger 2/24/06. Clinical History 47 yo F with vaginal bleeding and pelvic pain On exam, large cervical mass with parametrial involvement.
Cervix Dr. Raid Jastania. Cervical Cancer Screening HPV infection Pre- Cancerous Dysplasia Cancer years.
Cervical Cancer Cervical dysplasia Cervical cancer Causes Risk factors
District 1 ACOG Medical Student Teaching Module 2009
Benign and premalignant disease of the cervix
Female Genital Tract 1-Vulva 2-Vagina 3-Cervix 4-Uterine corpus
Cervical Cancer Source: SEER’s Training Web Site
Cervical Cancer: Prevention and Treatment
Jacqueline Castagno, MD FACOG Division of Gynecologic Oncology Department of Obstetrics and Gynecology University of Florida College of Medicine.
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
Case Presentations: Pre-Invasive Cervical Neoplasia
Dr. Maryam B. MAHMMUD. Incidence:  Cervical cancer is the most common form of cancer in women in developing countries.  Second most common form of carcinoma.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
CIN & Cervical Cancer Women ’ s Hospital, School of Medicine, Zhejiang university.
CANCER CERVIX A PREVENTABLE CANCER Dr NEETA DHABHAI Sr Consultant. – Gynaecologist Member Expert - Indian Cancer Winners’ Association
Stage II Stage II - Invasive cancer with tumor extending beyond the cervix and/or the upper two-thirds of the vagina, but not onto the pelvic wall. –Stage.
Fertility Sparing in Gynecological Cancers
Less Radical Surgery for Patients with Early-Stage Cervical Cancer Dr Marie Plante NCIC CTG, Cervix Working Group GCIG meeting Belgrade, Oct 10-11, 2009.
In the name of God Isfahan medical school Shahnaz Aram MD.
Cancer of Cervix Shashi. Sep-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. Potentially curable if detected early.
Abnormal Pap in Pregnancy Alexander Burnett, MD Division Gyn Oncology, UAMS April, 2006.
Endometrial Carcinoma
Tumors of Cervix.
In the Name of God. Screening of Cervical Cancer Pap smear and colposcopy F.Behnamfar Gynecology Oncology Fellowship Associate Professor Isfahan University.
Cervical Intraepithelial Neoplasm
Cancer of Cervix Shashi. Oct-15 Introduction: Best example of cancer prevention. Best example of cancer prevention. US Statistics: US Statistics: Leading.
Cancer Cx. Que-1 The most common gynecological malignancy in the world is – a) Vaginal Ca b) Cervical Ca c) Uterine Ca d) Ovarian Ca.
Cervical cancer. Epidemiology Cervical cancer is the 5 th most common cancer in women worldwide In some parts of Africa, South America and South Eastern.
Radiation Therapy in the Management of Cervical Carcinoma Patrick S Swift, MD Medical Director, Radiation Oncology Alta Bates Comprehensive Cancer Center.
Top Pap smear Questions. 1-When should Pap screening begin? Age 21 y/o,3yrs after first intercourse.
Uterine Cancers A. Alobaid, MBBS, FRCS(C), FACOG Consultant, Gynecologic Oncology Assistant professor, KSU Medical Director, Women’s Specialized Hospital.
Adult Medical-Surgical Nursing
Oncology / Dysplasia Unit Royal Women’s Hospital, Carlton, Victoria Do all patients with invasive cervical carcinoma need a radical hysterectomy? Leuven.
Cervical Cancer Xin LU OB/GYN Hospital Fudan University.
HspE7 INFECTIOUS DISEASE VACCINE FOR THE TREATMENT OF CERVICAL CARCINOMA.
In the name of God Cervical Cancer Dr.T allameh MD.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Cervical Cancer Kelley Ratermann, PharmD Hematology/Oncology Clinical Pharmacist.
2006 ASCCP Consensus Guidelines Anne L. Kittendorf, MD FAAFP Assistant Professor University of Michigan Department of Family Medicine.
Treatment for Cervical Cancer
HPV AND WOMEN’S CANCER A.C. Evans. M.D., Ph.D.. HPV and Women’s Cancer I have no relevant financial relationships with the manufacturer(s) of any commercial.
HPV-related anogenital cancers
DON`T LET UTERINE CERVICAL CARCINOMA DRIVE YOU CRAZY: BASIC MRI PRINCIPLES M. Gamo P. Ramos E. Diez E. Barcina P. Quintana.
Management of early stage cervical cancer
Trreatment of Preinvasive Lesions
Cervical Cancer Colposcopy & Treatment
Cervical Cancer Tiffany Smith HCP 102.
Uterine cancer Uterine mesenchymal neoplasms
Neoplasia of the cervix
SH-sheikhhasani Gyn-oncologist
ENDOMETRIAL CARCINOMA
Presentation transcript:

Cervical cancer Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology

Incidence of Cervical Cancer (GloboCan/IARC 2000) – in per women

Cervical cancer is a preventable cancer because it has a long preinvasive state. The incidence of CC is decreasing and it is being diagnosed earlier during last 50 years..... due to cervical cytology screening programs Mean age for cervical cancer is 50 years and it peaks at years and years.

Risk factors for development of CC sexuel intercourse at an early age multiple sexuel partners young age at first pregnancy cigarette smoking HSV infection HPV infection

HPV and Cervical Cancer International collection of cervical tumor specimens showed that HPV DNA is present in 99.7% of cases. Relative risks for the association between HPV and cervical cancer are in range.

The most important HPV types related to Cervical Preinvazive and invazive lesion Schiffman, J Nat Cancer Inst, 85:958, 1993 and Liaw, J Nat Cancer Inst, 91:954, 1999

Transmision: genital skin to skin contact Transient HPV infection Persistent infection with oncogenic HPV types LSIL/CIN IHSIL/CIN II - III Invasive cervical cancer Cofactors Hormonal Influances Parity Other STIs Smoking Nutritions Host genetics Viral genetics from Franco and Harper 2005, Trottier H,Franco EL, Vaccine 2006

 HPV with the assistance of some cofactors can result in the development of CC. All of the invasive squamous CC develope at the end of progressive pathologic events. NNormal epithel CIN I CIN II CIN III Cancer · Squamous carcinoma of the cervix arises at the active SCJ from pre-existing dysplastic lesion. Briefly

CIN I % 57 % 11 %0.3 Normal CIN II - III Cancer n: 4504 Ostor AG, 1993 CIN IICIN III % 43 Regress % 22 CIN III-Kanser % 14 Cancer % 30 % 35 % 56 CIN II CIN III Michell MF., 1996 Wright TC., 2002 Regress % 31 CIN I

H H ISTOLOGIC TYPES OF CC 1. squamous cell carcinoma....most common type 2. adenocarcinoma (AC)....in recent years, an increasing number of AC affecting young women....AC are populated by musinous endocervical cells, endometroid cells, clear cells % -15 of CC....considered that AC is poorly prognostic tumor compared with squamous cell carcinoma 3. minimal deviation adenocarcinoma(adenoma malignum).....extremely well-diferentiated form of AC 4. villoglandular papillary adenocarcinoma 5. adenosquamous carcinom 6. glassy cell carcinoma

S YMPTOMS 1. 20% of patients are asymtomatic.. vaginal bleeding postcoital, irregular men, postmenopausal 3. vaginal discharge 4.. pain

Asymptomatic abnormal cytology Symptomatic biopsy Diagnosis Colposcopic examination Biopsy

a. Conventional Pap test b. Liquid-based cytology Vaginal Cytology

Colposcopy

Punch biyopsy Leep excision Conization Biopsy techniques for cervical evaluation

LEEP Excision - Conization

Conization end-point diagnostic work-up for cervical pathology

PATTERNS OF SPREADING 1. Direct invasion into the cervical stroma, vagina, uterine corpus and parametrium 2. Lymphatic metastases 3. Hematologic metastases 4. Intraperitoneal metastases Predominanat spread patterns : direct extension and lymphatic dissemination Malignant cells spread by way of paracervival lymphatic cannels into the obturator, internal iliac, external iliac, common iliac and para-aortic lymph nodes group.

2009

Pathologic Prognostic Factors Related to Cervical Cancer Pelvic lymphatic status Tumor size Deep of invasion LVSI Close surgical margin Positive surgical margin

The Relationship of Pelvic Lymph Node Metastasis and 5-year Survival Monoghan % % Delgado % % Kamura % 64 63% Lai % % n Survival n Survival Node negative Node positive

The Main Prognostic Factors in Cervical Cancer Tumor size (cm) < 2 58 %94 < %79 >4 10 % 47 Depth of invasion(mm) <10 75 %94 < % %57 >20 9 %33 n 5-year survival p Kristensen et al, Gynecol Oncol 1999

The Influence of LVSI on Pelvic Lymph Node Metastasis and Survival in Early Stage Cervical Carcinoma Crissman % 8% 30 64% 17% Delgado % 8% % 25% Roman % % n survival pel nod + n survival pel nod + LVSI negative LVSI positive

Molacular Prognostic Factors of Cervical Cancer DNA cytometry COX-2 expression nm23 expression Tymidine kinase Beta-catanin Id-1 protein Matrix metaloproteinases and others

Treatment of Cervical Cancer

The principles of treatment for cervical cancer composed of.. Sites of spread Primary tumor Surgery Radiotherapy

Surgery Radiotherapy Stage Ia-Ib1- II a Stage Ib2-III-IV

The results of surgery and radiotherapy are almost equal Treatment of cervical cancer depends on patients age, sexual status, fertilty status If the patient is young and sexualy active, surgery is the best choise

Surgical Treatment Stage Ia1 Conization is adequate for women who desire fertility if there is no lymphovascular space invasion or Type I hysterectomy for women who not desire fertility

Surgical Treatment Stage Ia2 Type II or III hysterectomy with pelvic lymphadenectomy Stage Ib1- Stage IIa- Type III hysterectomy with pelvic lymphadenectomy

Radikal histerektomi and Lymphadenektomi

Radical Hysterectomy(Type II-III) for stage Ia2, Ib and IIa immediate therapy staging and tailoring of therapy conservation of the ovaries conservation of sexual function The results of surgery and radiotherapy are almost equal

After surgery if surgical margin is positive or lymph node is positive, postoperative RT is mandatory

Primer radio-chemotherapy is the best choise For stage Ib2 and > IIb diseases

Results of Trachelectomy n:130 Ia1 17 Ia2 36 Ib1 74 IIa 3 Squamous 93 Adeno ca 37 < 2 cm 110 > 2 cm 10 Intraop complication %9 Postop “ %10 Positive node %2.4 Mean follow-up 27 ay Tumor reccurrence %3.1 Pregnancy 54 Dargent 2000, Plante 1999, Covens 1999, Shepherd 1998 Fertility sparing surgery for cervical cancer